1. Gruenenthal Gmbh (21 from 357 patents)

2. Medifron Dbt Inc. (1 from 1 patent)

3. Grunenthal Gmbh (107 patents)

1. 9771359 - Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II

2. 9624209 - Substituted phenylureas and phenylamides as vanilloid receptor ligands

3. 9120756 - Substituted phenylureas and phenylamides as vanilloid receptor ligands

4. 8946204 - Substituted phenylureas and phenylamides as vanilloid receptor ligands

5. 8895623 - Intrathecal or epidural administration of 3-[(1S,25)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol

6. 8791268 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions

7. 8785474 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions

8. 8735426 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them and use thereof for treating pain and other conditions

9. 8710233 - Vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations

10. 8642623 - Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions

11. 8642775 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions

12. 8592471 - Substituted phenylureas and phenylamides as vanilloid receptor ligands

13. 8404740 - Spirocyclic cyclohexane compounds

14. 8357705 - Substituted cyclohexyldiamines

15. 8278338 - Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety